Hypertension Posts on Medivizor
Navigation Menu

Hypertension Posts on Medivizor

Evaluating the effectiveness and safety of aprocitentan for lowering blood pressure in patients with uncontrolled hypertension.

Evaluating the effectiveness and safety of aprocitentan for lowering blood pressure in patients with uncontrolled hypertension.

Posted by on Jul 2, 2023 in Hypertension | 0 comments

In a nutshell This study evaluated the effectiveness and safety of aprocitentan (ACT-132577) for lowering blood pressure (BP) in patients with resistant or uncontrolled hypertension (high BP). The data showed that aprocitentan was effective in lowering the BP after 4 weeks with a sustained effect after 40 weeks compared to a placebo with...

Read More

Evaluating the long-term outcomes of catheter-based renal artery denervation in patients with uncontrolled hypertension.

Evaluating the long-term outcomes of catheter-based renal artery denervation in patients with uncontrolled hypertension.

Posted by on Apr 23, 2023 in Hypertension | 0 comments

In a nutshell This study reported the long-term outcomes of catheter-based renal artery denervation (CB-RD) in patients with resistant or uncontrolled hypertension [high blood pressure (BP)]. The data showed that over the long-term CB-RD was safe and had significantly greater reductions in BP and better BP control compared with a sham control in these...

Read More

Evaluating the effectiveness and safety of high-dose rosuvastatin combined with telmisartan or amlodipine on glucose metabolism in hypertensive patients with impaired fasting glucose.

Evaluating the effectiveness and safety of high-dose rosuvastatin combined with telmisartan or amlodipine on glucose metabolism in hypertensive patients with impaired fasting glucose.

Posted by on Mar 26, 2023 in Hypertension | 0 comments

In a nutshell This study evaluated the effectiveness and safety of high-dose rosuvastatin (Crestor) combined with telmisartan (Micardis) or amlodipine (Norvasc) on glucose metabolism in patients with atherosclerotic cardiovascular disease (ASCVD), hypertension (high blood pressure), and impaired fasting glucose (IFG or prediabetes). The...

Read More

Recommendations for carbohydrate-restricted diets and intermittent fasting in patients with obesity, type 2 diabetes mellitus, and hypertension.

Recommendations for carbohydrate-restricted diets and intermittent fasting in patients with obesity, type 2 diabetes mellitus, and hypertension.

Posted by on Dec 30, 2022 in Hypertension | 0 comments

In a nutshell This study evaluated the effects of carbohydrate-restricted diets and intermittent fasting (IF) in patients with obesity, type 2 diabetes (T2D), and hypertension (high blood pressure). The authors recommended that in adults with T2D, overweight or obesity, a moderately-low carbohydrate diet can be considered as a dietary regimen for blood...

Read More

Evaluating the association between omega-3 polyunsaturated fatty acids dosage and blood pressure in patients with hypertension.

Evaluating the association between omega-3 polyunsaturated fatty acids dosage and blood pressure in patients with hypertension.

Posted by on Oct 16, 2022 in Hypertension | 0 comments

In a nutshell This study evaluated the association between omega-3 polyunsaturated fatty acids (PUFA) dosage (amount of drug administered) and blood pressure (BP) in patients with hypertension (high BP). The data showed that the optimal combined intake of omega-3 fatty acids for lowering BP is likely between 2 g/day and 3 g/day in these...

Read More

Evaluating the renin-angiotensin-aldosterone system inhibitors effects on mortality and disease severity in patients with COVID-19

Evaluating the renin-angiotensin-aldosterone system inhibitors effects on mortality and disease severity in patients with COVID-19

Posted by on Sep 18, 2022 in Hypertension | 0 comments

In a nutshell This review analyzed the effect of renin-angiotensin-aldosterone system (RAAS) inhibitors including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) on patient prognosis for COVID-19. The data suggested that there is no association between the use of ACEIs/ARBs and the risk of mortality and...

Read More

Evaluating the benefits of a more versus a less intensive blood pressure lowering treatment strategy in patients with hypertension.

Evaluating the benefits of a more versus a less intensive blood pressure lowering treatment strategy in patients with hypertension.

Posted by on May 31, 2022 in Hypertension | 0 comments

In a nutshell This study evaluated the benefits of a more versus a less intensive blood pressure (BP) lowering treatment strategy in patients with hypertension (high blood pressure). The data showed that a more intensive BP lowering treatment strategy significantly reduced the risks of stroke, heart failure, heart attacks, and cardiovascular death...

Read More

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Is there a long-term effect of weight loss surgery on major adverse cardiovascular events in patients with diabetes and hypertension?

Posted by on May 8, 2022 in Hypertension | 0 comments

In a nutshell This study evaluated the long-term relationship between bariatric surgery (BS; weight loss surgery) and major adverse cardiovascular events (MACE) in patients with obesity, diabetes, and hypertension (high blood pressure; BP). The study showed that a sustained decrease in MACE occurrence was associated with BS in these patients. Some...

Read More

Evaluating the effects of using regular acetaminophen on blood pressure in patients with hypertension.

Evaluating the effects of using regular acetaminophen on blood pressure in patients with hypertension.

Posted by on May 8, 2022 in Hypertension | 0 comments

In a nutshell This study evaluated the effects of using regular acetaminophen (Paracetamol) on blood pressure (BP) in patients with hypertension (high BP). The data showed that regular daily acetaminophen use increased BP in these patients and increased the risk of cardiovascular disease when compared with placebo. Some background Hypertension or high...

Read More

Do combination therapies given in fixed-doses polypills with aspirin reduce the risk of cardiovascular disease events?

Do combination therapies given in fixed-doses polypills with aspirin reduce the risk of cardiovascular disease events?

Posted by on Jan 16, 2022 in Hypertension | 0 comments

In a nutshell This study investigated whether a combination pill given in fixed doses with or without aspirin can reduce the risk of cardiovascular disease events in patients without a previous history of cardiovascular disease. The data showed that a fixed-dose combination treatment strategy with aspirin significantly reduced the risks of...

Read More

Evaluating the safety and effectiveness of a four-in-one blood pressure pill early-on in patients with hypertension.

Evaluating the safety and effectiveness of a four-in-one blood pressure pill early-on in patients with hypertension.

Posted by on Dec 19, 2021 in Hypertension | 0 comments

In a nutshell This study investigated whether a single blood pressure (BP) pill containing 4 drugs (quadpill) at quarter doses is more effective than the standard dose of a single drug as initial treatment in patients with hypertension. The data showed that a quadpill was safe and more effective in getting BP under control than the standard...

Read More

Lifestyle changes for patients with high blood pressure resistant to medications

Lifestyle changes for patients with high blood pressure resistant to medications

Posted by on Dec 19, 2021 in Hypertension | 0 comments

In a nutshell This study looked at the effects of diet and lifestyle changes for people with high blood pressure who did not respond to medication. It found that a four-month counseling program led to significant improvement in diet and exercise, blood pressure, and heart health. Some background Uncontrolled high blood pressure leads to cardiovascular...

Read More